(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)
Louvain-la-Neuve, Belgium, April 28th, 2024 06:00 PM
Summary of the notification
IBA (Ion Beam Applications), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on April 8th, 2025.
In its notification, FMR LLC indicated that following an acquisition or disposal of securities or voting rights, 1% threshold crossed downards by Fidelity Management & Research Company LLC, a controlled undertaking of FMR LLC on 3/04/2025.
Content of the notification
Name | Address (for legal entities) |
FMR LLC | The Corporation Trust Center, 1209 Orange Street, Wilmington, New Castle County, Delaware, 19801. |
A) Voting rights | Previous notification | After the transaction | |||
# of voting rights | # of voting rights | % of voting rights | |||
Holders of voting rights | Linked to securities | Not linked to the securities | Linked to securities | Not linked to the Securities | |
FMR LLC | 0 | 0 | |||
Fidelity Management & Research Company LLC | 408,246 | 397,873 | 0.98% | ||
FIAM LLC | 5,979 | 11,777 | 0.03% | ||
FMR Investment Management (UK) Limited | 0 | 170,000 | 0.42% | ||
Subtotal | 414,225 | 579,650 | 1.43% | ||
TOTAL | 579,650 | 0 | 1.43% | 0.00% |
B) Equivalent financial instruments | After the transaction | ||||||
Holders of equivalent financial instruments | Type of financial instrument | Expiration date | Exercise period or date | # of voting rights that may be acquired if the instrument is exercised | % of voting rights | Settlement | |
TOTAL | 0 | 0.00% |
TOTAL (A & B) | # of voting rights | % of voting rights | |
579,650 | 1.43% | ||
FIAM LLC is controlled by FIAM Holdings LLC; FMR Investment Management (UK) Limited is controlled by Fidelity Management & Research Company LLC; FIAM Holdings LLC, Fidelity Management & Research Company LLC are controlled by FMR LLC;
FMR LLC is not a controlled undertaking.
The holdings attributed to the entities mentioned in the table arise from holdings of various undertakings for collective investment that are managed by FIAM LLC, FMR Investment Management (UK) Limited, and Fidelity Management & Research Company LLC each of which are entities that are subsidiaries of and controlled by FMR LLC. The entities mentioned in the table are the discretionary investment managers and exercise the voting rights at their discretion in the absence of specific instructions.
1% threshold, as stipulated in the Articles of Association, crossed downards by Fidelity Management & Research Company LLC, a controlled undertaking of FMR LLC.
About IBA
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered as the most advanced form of radiation therapy available today, as well as industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,100 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at: www.iba-worldwide.com
For further information, please contact:
Elena De Landy
Paralegal: Corporate Affairs and Insurance
legal@iba-group.com
Attachment
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.